特刊：IgA肾病发病机制与治疗的新见解
Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy.
作者信息
Suzuki Hitoshi, Novak Jan
机构信息
Department of Nephrology, Juntendo University Urayasu Hospital, Chiba 279-0021, Japan.
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
出版信息
J Clin Med. 2022 Jul 28;11(15):4378. doi: 10.3390/jcm11154378.
Abstract
IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide [...].
摘要
IgA肾病（IgAN）是全球原发性肾小球肾炎最常见的形式[...]。
相似文献
1
Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy.特刊：IgA肾病发病机制与治疗的新见解
J Clin Med. 2022 Jul 28;11(15):4378. doi: 10.3390/jcm11154378.
2
New insights into pathogenesis of IgA nephropathy.IgA 肾病发病机制的新见解。
Int Urol Nephrol. 2022 Aug;54(8):1873-1880. doi: 10.1007/s11255-021-03094-0. Epub 2022 Jan 20.
3
New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production?IgA肾病发病机制的新见解：Toll样受体9- B细胞活化因子-IgA类别转换重组信号轴是否诱导IgA产生过多？
Ren Fail. 2014 Jul;36(6):970-3. doi: 10.3109/0886022X.2014.916578. Epub 2014 May 15.
4
The Role of Immune Modulation in Pathogenesis of IgA Nephropathy.免疫调节在IgA肾病发病机制中的作用
Front Med (Lausanne). 2020 Mar 24;7:92. doi: 10.3389/fmed.2020.00092. eCollection 2020.
5
The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.补体蛋白作为 IgA 肾病治疗靶点的新作用。
Front Immunol. 2019 Mar 19;10:504. doi: 10.3389/fimmu.2019.00504. eCollection 2019.
6
Update on treatment of immunoglobulin A nephropathy.免疫球蛋白A肾病的治疗进展
Nephrology (Carlton). 2018 Oct;23 Suppl 4:62-67. doi: 10.1111/nep.13453.
7
Clinical and histological features and therapeutic strategies for IgA nephropathy.IgA 肾病的临床和组织学特征及治疗策略。
Clin Exp Nephrol. 2019 Sep;23(9):1089-1099. doi: 10.1007/s10157-019-01735-4. Epub 2019 Apr 9.
8
A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.一种原发性肾小球肾炎三种类型免疫球蛋白和补体的病理与血清学水平的初步对比研究。
BMC Immunol. 2018 Jun 20;19(1):18. doi: 10.1186/s12865-018-0254-z.
9
The IgA nephropathy treatment dilemma.IgA肾病的治疗困境。
Kidney Int. 2006 Jun;69(11):1939-44. doi: 10.1038/sj.ki.5000434.
10
Non-immunosuppressive therapies for childhood IgA nephropathy.儿童IgA肾病的非免疫抑制疗法。
Pediatr Nephrol. 2021 Oct;36(10):3057-3065. doi: 10.1007/s00467-021-04954-8. Epub 2021 Feb 16.
引用本文的文献
1
Refractory IgA Nephropathy: A Challenge for Future Nephrologists.难治性 IgA 肾病：未来肾脏病学家面临的挑战。
Medicina (Kaunas). 2024 Feb 5;60(2):274. doi: 10.3390/medicina60020274.
2
Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease.IgA 肾病、IgA 血管炎和川崎病患者的肠道微生物组景观。
Front Cell Infect Microbiol. 2022 Dec 16;12:1061629. doi: 10.3389/fcimb.2022.1061629. eCollection 2022.
本文引用的文献
1
Crescents and IgA Nephropathy: A Delicate Marriage.新月体与IgA肾病：一段微妙的关系
J Clin Med. 2022 Jun 21;11(13):3569. doi: 10.3390/jcm11133569.
2
Glomerular deposition of galactose-deficient IgA1-containing immune complexes via glomerular endothelial cell injuries.通过肾小球内皮细胞损伤导致半乳糖缺陷 IgA1 免疫复合物在肾小球沉积。
Nephrol Dial Transplant. 2022 Aug 22;37(9):1629-1636. doi: 10.1093/ndt/gfac204.
3
Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.半乳糖缺乏型IgA1作为IgA肾病的候选尿液标志物
J Clin Med. 2022 Jun 2;11(11):3173. doi: 10.3390/jcm11113173.
4
New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies.IgA肾病的新治疗策略：以浆细胞作为致病性抗体的主要来源为靶点
J Clin Med. 2022 May 16;11(10):2810. doi: 10.3390/jcm11102810.
5
IgA Vasculitis with Nephritis in Adults: Histological and Clinical Assessment.成人IgA血管炎伴肾炎：组织学和临床评估
J Clin Med. 2021 Oct 22;10(21):4851. doi: 10.3390/jcm10214851.
6
The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?补体在IgA肾病发病机制中的作用：补体靶向治疗是否正从罕见疾病转向更常见疾病？
J Clin Med. 2021 Oct 14;10(20):4715. doi: 10.3390/jcm10204715.
7
Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment.IgA肾病的发病机制：当前的认识及对疾病特异性治疗发展的启示
J Clin Med. 2021 Sep 29;10(19):4501. doi: 10.3390/jcm10194501.
8
The Role of Complement Component C3 Activation in the Clinical Presentation and Prognosis of IgA Nephropathy-A National Study in Children.补体成分C3激活在儿童IgA肾病临床表现及预后中的作用——一项全国性儿童研究
J Clin Med. 2021 Sep 26;10(19):4405. doi: 10.3390/jcm10194405.
9
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.IgA肾病中糖基化异常的IgA1：我们所知道的和未知的
J Clin Med. 2021 Aug 5;10(16):3467. doi: 10.3390/jcm10163467.
10
History of IgA Nephropathy Mouse Models.IgA肾病小鼠模型的历史。
J Clin Med. 2021 Jul 16;10(14):3142. doi: 10.3390/jcm10143142.
Zotero 插件